Effectiveness of quetiapine in Borderline personality disorder; Mental and Behavioural Disorders
The registry lists this study as recruiting. Study locations are listed in the United Kingdom. Confirm recruitment at each site. It is testing quetiapine for Borderline personality disorder; Mental and Behavioural Disorders.
Understand this study
Who could participate?
Listed age limits: 18 years to 100 years.
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- University of Liverpool
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Study phase
- Phase IIIThis study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United Kingdom
- Age range
- From 18 Years to 100 Years
- Official registry ID
- ISRCTN16864220
- Official title
- The clinical and cost effectiveness of quetiapine for people with borderline personality disorder: A pragmatic, double-blind, placebo-controlled, randomised trial
Recruitment & locations
RecruitingUnited Kingdom
Registry details
Borderline personality disorder; Mental and Behavioural Disorders
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University of Liverpool, a university.
Who can participate?
Listed age limits: 18 years to 100 years.
Is this study still recruiting?
The registry lists this study as recruiting.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me